查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2074945

機器人輔助手術市場預測至2034年—按產品類型、手術專科、技術、最終用戶和地區分類的全球分析

Robotic-Assisted Surgery Market Forecasts to 2034 - Global Analysis By Product Type (Surgical Systems, Instruments & Accessories and Services & Maintenance), Surgical Specialty, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球機器人輔助手術市場規模將達到 128 億美元，並在預測期內以 13.3% 的複合年成長率成長，到 2034 年將達到 346 億美元。

機器人輔助手術是一種前沿的外科手術方法，能夠顯著提升外科醫生在複雜手術中的精準度、靈活性和控制力。它利用電腦控制的機器人平台，將外科醫生的手部動作轉化為極其精準的細微動作。機器人輔助手術主要用於微創手術，可減少出血量、縮小切口、減輕術後疼痛並加速患者復原。目前，該技術已廣泛應用於泌尿系統、婦科、心胸外科和一般外科等多個專科領域。先進的3D高清成像技術進一步提升了手術過程中的精準度和可視性。隨著醫療技術的進步，機器人輔助手術正在全球迅速發展，為提升全球治療效果和手術安全性做出了貢獻。

根據美國泌尿系統協會（AUA，2022 年）的數據，美國超過 85% 的根治性攝護腺切除術採用機器人輔助技術進行，使其成為泌尿系統領域的主流手術方法。

慢性病盛行率增加

慢性疾病（包括癌症、心臟病和泌尿系統疾病）發生率的不斷上升，顯著推動了對機器人輔助手術的需求。治療這些疾病通常需要進行複雜的手術，而高精度至關重要。機器人系統支援微創手術，從而減少併發症、縮短住院時間並加快患者康復。隨著人口老化和生活方式的改變，慢性疾病日益普遍，對先進手術方案的需求也日益成長。這促使醫療機構擴大採用機器人解決方案，以改善治療效果並提升患者照護水準。

機器人系統和手術高成本

機器人輔助手術普及應用的主要障礙之一是機器人系統及相關手術的高成本。這些技術需要大量的初始投資，以及持續的維護、耗材和系統升級費用。許多醫療機構，尤其是在中低收入地區，難以負擔如此昂貴的設備。此外，由於機器人手術通常比傳統手術更昂貴，缺乏足夠保險的患者仍然難以獲得這項服務。儘管機器人手術具有許多臨床優勢，但其整體經濟負擔仍是一個巨大的挑戰，也是全球推廣機器人手術的限制因素。

手術機器人技術的進步

手術機器人技術的不斷進步為市場拓展創造了巨大的機會。影像技術、機器人精密器械、觸覺回饋系統和人工智慧的創新正在提高手術的精確度和效率。這些進步也為遠距手術和遠距外科技術的發展提供了支持，從而改善了不同地區獲得專科醫療服務的機會。持續的研發投入正在打造更緊湊、經濟高效且適應性更強的機器人系統。因此，越來越多的醫院和醫療中心正在採用這些技術。隨著科技的進一步發展，機器人輔助手術有望變得更有效率且便捷，並在全球各個醫療領域中廣泛應用。

技術故障和系統錯誤的風險

依賴複雜的機器人系統會帶來技術故障和操作失誤的風險，這對市場構成重大威脅。由於這些系統整合了先進的軟硬體，手術過程中任何錯誤或故障都可能危及病患安全。系統崩潰、軟體故障和機械故障都可能中斷手術，並增加併發症的風險。嚴重依賴這些技術的醫院可能會面臨營運中斷。這些擔憂會削弱醫療專業人員的信任，並減緩機器人技術的普及速度。儘管技術不斷進步，但系統故障的可能性仍然是機器人輔助手術在複雜臨床環境中應用的一大挑戰。

新型冠狀病毒（COVID-19）的影響：

新冠疫情為機器人輔助手術市場帶來了挑戰與機會。疫情初期，許多擇期手術被延後或取消，導致機器人手術系統的使用量下降，醫院活動減少。醫療機構將重心轉移到治療新冠患者上，限制了手術數量和可用資源。然而，隨著疫情好轉，機器人輔助手術憑藉其微創、縮短住院時間和降低感染風險等優勢，需求逐漸恢復。疫情過後，醫院擴大採用先進的手術技術，推動了醫療機構對機器人手術系統的復甦和新的投資。

在預測期內，外科手術系統細分市場預計將佔據最大的市場佔有率。

預計在預測期內，手術系統領域將佔據最大的市場佔有率，因為它是進行機器人手術的主要技術平台。這些系統結合了機器人機械手臂、手術控制單元、視覺化工具和整合軟體，從而能夠進行精準的手術。醫療機構正致力於採用手術系統，因為它們對於建立機器人手術能力至關重要。微創手術日益普及以及技術的偏好進步進一步鞏固了該領域在市場上的主導地位。持續的升級和在各個外科領域的臨床應用不斷擴展，也為該領域在全球範圍內保持強勁且永續的領先地位做出了貢獻。

預計泌尿系統領域在預測期內將呈現最高的複合年成長率。

在預測期內，泌尿系統領域預計將呈現最高的成長率，這主要受前列腺癌、腎臟疾病和其他泌尿系統疾病發病率上升的推動。泌尿系統輔助系統因其在精細解剖區域提供更高的精準度、更佳的視野和更好的控制，而被廣泛應用於泌尿外科手術。微創手術（尤其是在前列腺和腎臟手術方面）的日益普及推動了機器人輔助系統的應用。治療效果的改善、更快的康復和更少的併發症也促進了其進一步成長。這些因素共同作用，使泌尿系統成為全球機器人輔助手術市場中成長最快的領域。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高度發達的醫療保健體系、先進醫療技術的快速普及以及行業領先企業的強大影響力。該地區擁有許多現代化醫院和手術中心，這些機構廣泛採用機器人系統進行複雜手術。完善的保險報銷機制和高額的醫療費用支出進一步鞏固了其主導地位。慢性病盛行率的上升以及人們對微創手術日益成長的偏好也推動了市場需求。此外，持續的創新和強大的研發投入已使北美成為全球領先的機器人輔助手術技術區域市場之一。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療基礎設施的持續發展和對先進醫療技術投資的增加。患者數量和慢性病病例的激增推動了對微創手術的強勁需求。醫療旅遊的成長、醫療支出的增加以及政府的大力支持進一步促進了微創手術的普及。中國、印度和日本等領先國家正大力投資機器人手術解決方案。此外，醫護人員和患者對機器人手術的認知不斷提高，也推動了機器人輔助手術在全部區域迅速發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球機器人輔助手術市場：依產品類型分類

  • 外科系統
  • 設備和配件
  • 服務與維護

第6章：全球機器人輔助手術市場：依外科專科分類

  • 一般外科
  • 整形外科手術
  • 神經外科
  • 泌尿系統
  • 婦科
  • 心胸外科
  • 其他專科手術

第7章：全球機器人輔助手術市場：依技術分類

  • 遠端機器人
  • 微創機器人系統
  • 自主系統和人工智慧整合系統

第8章：全球機器人輔助手術市場：依最終用戶分類

  • 醫院
  • 門診手術中心（ASC）
  • 專科診所

第9章：全球機器人輔助手術市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Intuitive Surgical
  • Stryker Corporation
  • Medtronic
  • Johnson & Johnson
  • Zimmer Biomet
  • Smith & Nephew
  • Siemens Healthineers
  • Asensus Surgical
  • CMR Surgical
  • Brainlab
  • Renishaw
  • Titan Medical
  • Meerecompany
  • Think Surgical
  • Globus Medical
  • MicroPort
  • Distalmotion
  • Vicarious Surgical
Product Code: SMRC37408

According to Stratistics MRC, the Global Robotic-Assisted Surgery Market is accounted for $12.8 billion in 2026 and is expected to reach $34.6 billion by 2034 growing at a CAGR of 13.3% during the forecast period. Robotic-assisted surgery represents a modern surgical approach that improves a surgeon's precision, dexterity, and control in complex operations. It works through computer-guided robotic platforms that convert the surgeon's hand movements into highly accurate micro-movements. It is primarily used in minimally invasive procedures, leading to less blood loss, smaller surgical cuts, reduced pain after surgery, and quicker patient recovery. It is widely adopted across specialties such as urology, gynecology, cardiothoracic, and general surgery. Advanced 3D high-definition imaging enhances surgical precision and visibility during operations. As medical technology a progress, robotic-assisted surgery is expanding globally, contributing to improved outcomes and safer procedures worldwide.

According to the American Urological Association (AUA, 2022), more than 85% of prostatectomies in the United States are performed using robotic-assisted techniques, making it the dominant surgical approach in urology.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The growing incidence of chronic illnesses, including cancer, heart diseases, and urological disorders, is significantly fueling the demand for robotic-assisted surgery. Such medical conditions frequently require intricate surgical interventions where high accuracy is essential. Robotic systems support minimally invasive techniques that help lower complications, shorten hospitalization periods, and speed up patient recovery. With chronic diseases becoming more widespread due to aging demographics and changing lifestyles, the need for advanced surgical options is rising. This has led healthcare institutions to increasingly integrate robotic solutions to enhance treatment effectiveness and improve patient care outcomes.

Restraint:

High cost of robotic systems and procedures

One of the key barriers to the growth of robotic-assisted surgery is the expensive nature of robotic systems and related procedures. These technologies require significant upfront capital investment as well as continuous spending on maintenance, consumables, and system upgrades. Many healthcare facilities, particularly in low- and middle-income regions, struggle to afford such high-cost equipment. In addition, robotic surgeries are generally more expensive than conventional methods, making them less accessible to patients without strong insurance support. Despite clinical advantages, the overall financial burden remains a major challenge limiting widespread adoption in the global healthcare sector.

Opportunity:

Technological advancements in surgical robotics

Ongoing advancements in surgical robotics create strong opportunities for market expansion. Innovations in imaging technology, robotic precision tools, haptic feedback systems, and artificial intelligence are enhancing surgical performance and efficiency. These developments also support remote and tele-surgical procedures, improving access to expert care in different locations. Continuous R&D efforts are producing more compact, cost-effective, and adaptable robotic systems. As a result, hospitals and healthcare centers are increasingly adopting these technologies. With further technological progress, robotic-assisted surgery is expected to become more efficient, accessible, and widely implemented across various medical disciplines globally.

Threat:

Risk of technological failures and system errors

The reliance on complex robotic systems introduces risks of technical malfunctions and operational failures, which act as a major threat to the market. Because these systems integrate advanced software and hardware, any error or breakdown during surgery can endanger patient safety. Issues such as system crashes, software glitches, or mechanical faults may interrupt procedures and increase complications. Hospitals depending heavily on such technologies may face operational disruptions. These concerns reduce trust among medical professionals and slow down adoption. Even with ongoing advancements, the possibility of system failure remains a critical challenge for robotic-assisted surgery usage in sensitive clinical settings.

Covid-19 Impact:

The COVID-19 pandemic created both challenges and opportunities for the robotic-assisted surgery market. In the early stages, many elective surgeries were delayed or canceled, resulting in lower usage of robotic surgical systems and reduced hospital activity. Healthcare facilities shifted their focus toward managing COVID-19 cases, limiting surgical procedures and resource availability. However, as conditions improved, demand rebounded as robotic-assisted surgery offered benefits such as minimally invasive procedures, shorter hospital stays, and reduced infection risks. Post-pandemic, hospitals increasingly adopted advanced surgical technologies, driving recovery and renewed investment in robotic surgical systems across healthcare institutions.

The surgical systems segment is expected to be the largest during the forecast period

The surgical systems segment is expected to account for the largest market share during the forecast period as they serve as the primary technology platform for performing robotic procedures. These systems combine robotic manipulators, surgeon control units, visualization tools, and integrated software to enable precise surgical execution. Healthcare facilities focus heavily on adopting surgical systems since they are essential for establishing robotic surgery capabilities. Increasing preference for minimally invasive operations and ongoing technological improvements further enhance their market leadership. Continuous upgrades and expanding clinical applications across various surgical fields contribute to the strong and sustained dominance of this segment worldwide.

The urology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the urology segment is predicted to witness the highest growth rate, primarily driven by the rising incidence of conditions such as prostate cancer, kidney disorders, and other urinary tract diseases. Robotic-assisted systems are extensively utilized in urological surgeries because they provide superior precision, enhanced visualization, and better control in sensitive anatomical areas. Increasing preference for minimally invasive procedures, especially in prostate and kidney operations, is boosting adoption. Improved patient outcomes, faster recovery, and reduced complications are further supporting growth. These factors collectively make urology the fastest-expanding segment in the global robotic-assisted surgery market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to its highly developed healthcare system, rapid adoption of advanced medical technologies, and strong presence of key industry companies. The region is characterized by a large number of modern hospitals and surgical facilities that widely implement robotic systems for complex operations. Supportive reimbursement structures and high healthcare expenditure further strengthen its leadership. Growing cases of chronic illnesses and increasing preference for minimally invasive procedures also drive demand. Moreover, ongoing innovation and strong R&D initiatives reinforce North America's position as the leading regional market for robotic-assisted surgical technologies globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by continuous development of healthcare infrastructure and rising investment in advanced medical technologies. A large patient base and increasing cases of chronic diseases are driving strong demand for minimally invasive procedures. Growth in medical tourism, higher healthcare spending, and favorable government support are further encouraging adoption. Key countries like China, India, and Japan are investing heavily in robotic surgical solutions. Moreover, increasing awareness among medical professionals and patients is contributing to the rapid expansion of robotic-assisted surgery across the region.

Key players in the market

Some of the key players in Robotic-Assisted Surgery Market include Intuitive Surgical, Stryker Corporation, Medtronic, Johnson & Johnson, Zimmer Biomet, Smith & Nephew, Siemens Healthineers, Asensus Surgical, CMR Surgical, Brainlab, Renishaw, Titan Medical, Meerecompany, Think Surgical, Globus Medical, MicroPort, Distalmotion and Vicarious Surgical.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

In September 2025, Stryker and Siemens Healthineers announced a strategic partnership in the field of neurovascular robotics. The collaboration aims to develop a unique robotic system capable of performing a comprehensive range of elective and emergency neurovascular procedures, including treatment for strokes and aneurysms.

Product Types Covered:

  • Surgical Systems
  • Instruments & Accessories
  • Services & Maintenance

Surgical Specialties Covered:

  • General Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Urology
  • Gynecology
  • Cardiothoracic Surgery
  • Other Specialized Surgeries

Technologies Covered:

  • Telerobotics
  • Minimally Invasive Robotic Systems
  • Autonomous & AI-Integrated Systems

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Robotic-Assisted Surgery Market, By Product Type

  • 5.1 Surgical Systems
  • 5.2 Instruments & Accessories
  • 5.3 Services & Maintenance

6 Global Robotic-Assisted Surgery Market, By Surgical Specialty

  • 6.1 General Surgery
  • 6.2 Orthopedic Surgery
  • 6.3 Neurosurgery
  • 6.4 Urology
  • 6.5 Gynecology
  • 6.6 Cardiothoracic Surgery
  • 6.7 Other Specialized Surgeries

7 Global Robotic-Assisted Surgery Market, By Technology

  • 7.1 Telerobotics
  • 7.2 Minimally Invasive Robotic Systems
  • 7.3 Autonomous & AI-Integrated Systems

8 Global Robotic-Assisted Surgery Market, By End User

  • 8.1 Hospitals
  • 8.2 Ambulatory Surgical Centers (ASCs)
  • 8.3 Specialty Clinics

9 Global Robotic-Assisted Surgery Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Intuitive Surgical
  • 12.2 Stryker Corporation
  • 12.3 Medtronic
  • 12.4 Johnson & Johnson
  • 12.5 Zimmer Biomet
  • 12.6 Smith & Nephew
  • 12.7 Siemens Healthineers
  • 12.8 Asensus Surgical
  • 12.9 CMR Surgical
  • 12.10 Brainlab
  • 12.11 Renishaw
  • 12.12 Titan Medical
  • 12.13 Meerecompany
  • 12.14 Think Surgical
  • 12.15 Globus Medical
  • 12.16 MicroPort
  • 12.17 Distalmotion
  • 12.18 Vicarious Surgical

List of Tables

  • Table 1 Global Robotic-Assisted Surgery Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Robotic-Assisted Surgery Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Robotic-Assisted Surgery Market Outlook, By Surgical Systems (2023-2034) ($MN)
  • Table 4 Global Robotic-Assisted Surgery Market Outlook, By Instruments & Accessories (2023-2034) ($MN)
  • Table 5 Global Robotic-Assisted Surgery Market Outlook, By Services & Maintenance (2023-2034) ($MN)
  • Table 6 Global Robotic-Assisted Surgery Market Outlook, By Surgical Specialty (2023-2034) ($MN)
  • Table 7 Global Robotic-Assisted Surgery Market Outlook, By General Surgery (2023-2034) ($MN)
  • Table 8 Global Robotic-Assisted Surgery Market Outlook, By Orthopedic Surgery (2023-2034) ($MN)
  • Table 9 Global Robotic-Assisted Surgery Market Outlook, By Neurosurgery (2023-2034) ($MN)
  • Table 10 Global Robotic-Assisted Surgery Market Outlook, By Urology (2023-2034) ($MN)
  • Table 11 Global Robotic-Assisted Surgery Market Outlook, By Gynecology (2023-2034) ($MN)
  • Table 12 Global Robotic-Assisted Surgery Market Outlook, By Cardiothoracic Surgery (2023-2034) ($MN)
  • Table 13 Global Robotic-Assisted Surgery Market Outlook, By Other Specialized Surgeries (2023-2034) ($MN)
  • Table 14 Global Robotic-Assisted Surgery Market Outlook, By Technology (2023-2034) ($MN)
  • Table 15 Global Robotic-Assisted Surgery Market Outlook, By Telerobotics (2023-2034) ($MN)
  • Table 16 Global Robotic-Assisted Surgery Market Outlook, By Minimally Invasive Robotic Systems (2023-2034) ($MN)
  • Table 17 Global Robotic-Assisted Surgery Market Outlook, By Autonomous & AI-Integrated Systems (2023-2034) ($MN)
  • Table 18 Global Robotic-Assisted Surgery Market Outlook, By End User (2023-2034) ($MN)
  • Table 19 Global Robotic-Assisted Surgery Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 20 Global Robotic-Assisted Surgery Market Outlook, By Ambulatory Surgical Centers (ASCs) (2023-2034) ($MN)
  • Table 21 Global Robotic-Assisted Surgery Market Outlook, By Specialty Clinics (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.